Eurofins Strategy and Objectives

Eurofins' mission is to contribute to a safer and healthier world by providing our customers with innovative and high quality laboratory, research and advisory services whilst creating opportunities for our employees and generating sustainable shareholder value.

Eurofins operates in a range of clearly defined markets that its leadership believe have high growth potential and where competition is generally still fragmented.

Eurofins is structured as a decentralised network of independent companies. Leaders of each of the Group’s businesses develop with their teams their own strategy and business plans. Indeed, the Group does not operate under one single strategy, but with several that are specific to each market in which subsidiary companies operate. In general, Eurofins companies and groups thereof, constituting regional or global business lines, employ all or a combination of the following to develop a unique offering for their clients and, as a result, build strong market positions and defendable and sustainable competitive advantage:

• Use advanced technologies, supported by a high level of R&D and bespoke IT solutions;
• Deliver standardised, accredited services of high quality;
• Leverage Eurofins' growing global network of laboratories and service/product portfolio to generate scale effects (in particular top line synergies from cross-selling services offered by other laboratories in the network) and position themselves as a first choice provider based on innovation, quality, breadth and depth of offering; and
• Strive to become, over time, and remain the number one or number two service provider in every niche laboratory testing market in which they operate.

Each laboratory strives for operational excellence and aspires to be the best partner for its clients by leveraging the Group's network capabilities. This can be achieved for example through sharing of know-how and best practice across continents, world class IT infrastructure and bespoke IT solutions, integrated logistics and significant investments in R&D and laboratory infrastructure to develop better and well differentiated services. Becoming the leading and preferred provider has been achieved across many countries and market segments during the last 35 years by following this long term focussed significant investment program. The Group aims to achieve growth through organic development (selling more to existing customers and attracting new customers) and selective acquisitions which facilitate access to new customers, geographic markets, technologies, and innovation.